
About Shire Biotech India Private Limited
Data last updated:
Shire Biotech India Private Limited was a foreign private limited company based in Gurgaon, Haryana, India, operated as a subsidiary of Shire Pharmaceuticals Ireland Limited, Ireland. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the biotechnology segment of the life sciences sector. It was incorporated on 22 September 2017.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909HR2017FTC070872. Its GSTIN is 06AAZCS2579N1Z8 (Haryana). The company held 2 GST registrations, all of them active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors including Anoop Kishore Kamat and Rajesh Eric Dmellokamath.
Its last annual general meeting (AGM) was held on 20 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at 6th Floor Tower C Building No. 8 DLF Cyber City DLF Phase II, Gurgaon, Haryana, India – 122001.
As per the financials filed for FY 2022, the company reported a revenue of ₹13.91 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹4.15 Lakh (net margin 0.3%) and EBITDA of ₹6.4 Lakh (EBITDA margin 0.5%).
The company was associated with 4 brands: JanusHire, DocShire, Fastershire and Takeda Pharmaceuticals. Court records list 2 cases involving the company, including 2 filed by the company.
The last known website on record is shire.com.
Company details
Contact details
Shire Biotech India Private Limited's registered office is in Gurgaon, Haryana. Its website is shire.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address6th Floor Tower C Building No. 8 DLF Cyber City DLF Phase II, Gurgaon, Haryana, India – 122001
- IndustryLife Sciences, Biotechnology
To see the full contact details of Shire Biotech India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Shire Biotech India operates multiple associated brands including JanusHire, DocShire, and Fastershire. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Platform assists executives in Shared Services with job search and applications. | janushire.com | |
| A mobile app that enables users to chat with doctors for healthcare consultations. | docshire.com | |
| Provides fiber-optic telecom services for high-speed internet connectivity. | fastershire.com | |
| Rare disease treatments are developed by a specialty biopharmaceutical firm. | shire.com |
Business activity
The main business activity of Shire Biotech India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Shire Biotech India Private Limited, buy the company report.
Financials of Shire Biotech India Private Limited
FY 2022 filings availableShire Biotech India Private Limited reported revenue of ₹13.91 Cr (up 24% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 24% in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹13.91 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shire Biotech India Private Limited, buy the company report.
Board of directors of Shire Biotech India Private Limited
Shire Biotech India has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anoop Kishore Kamat Also directs: Takeda Biopharmaceuticals India Private Limited | Director | 23 Apr 2021 | 5 Years 6 Months | As last reported |
| Rajesh Eric Dmellokamath | Director | 31 Jul 2021 | 5 Years 3 Months | As last reported |
| Gopal Agrawal | Director | 08 Aug 2019 | 7 Years 3 Months | As last reported |
| Serina Magner Fischer | Director | 16 Mar 2022 | 4 Years 8 Months | As last reported |
Peer comparison
Shire Biotech India Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| VHB Life Sciences Limited | ₹13.99 Cr (FY 2025) | -74.0% | Kandivlai West, Maharashtra, India | |||
| Shire Biotech India Private Limitedthis company | ₹13.91 Cr (FY 2022) | ₹4.15 Lakh | 0.3% | 24.0% | Gurgaon, Haryana, India | |
| Trinity Pharmaceuticals & Food Private Limited | ₹13.88 Cr (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Unilex Lifesciences Private Limited | ₹13.82 Cr (FY 2024) | 22.0% | Panampilly Nagar, Kerala, India |
To see the full peer comparison of Shire Biotech India Private Limited, buy the company report.
Auditor
Shire Biotech India Private Limited is audited by B S R & Co. LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S R & Co. LLP | FY 2020 | 101248W/W100022 |
Shareholding
The shareholding of Shire Biotech India Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Shire Biotech India Private Limited, buy the company report.
Legal cases
Shire Biotech India Private Limited has 2 court cases on record: 2 filed by Shire Biotech India. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Chandigarh | Court case (C.P.(CAA)) | Filed by the company | Disposed |
| NCLT, Chandigarh | Court case (C.A.(CAA)) | Filed by the company | Disposed |
To see the full case history of Shire Biotech India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shire Biotech India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shire Biotech India has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAZCS2579N1Z8 | Haryana | Active | 15 Dec 2017 |
| 07AAZCS2579N1Z6 | Delhi | Active | 15 Dec 2017 |
To see the full GST registrations and return filing status of Shire Biotech India Private Limited, buy the company report.
Recent activity
Shire Biotech India Private Limited has 12 board changes on record since 2019: 4 appointments and 8 cessations. The latest: Serina Magner Fischer ceased to be Additional Director on 20 Sep 2022.
3 earlier events are in the company report.
News
Frequently asked questions
Shire Biotech India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Shire Biotech India was a foreign private limited company based in Gurgaon, Haryana, India. The company worked in biotechnology, within the life sciences industry. It was incorporated on 22 September 2017 and is registered under CIN U51909HR2017FTC070872. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Shire Biotech India was incorporated on 22 September 2017. It is registered with the Registrar of Companies, Delhi.
Shire Biotech India had 4 directors:
- Anoop Kishore Kamat - Director
- Rajesh Eric Dmellokamath - Director
- Gopal Agrawal - Director
- Serina Magner Fischer - Director
The CIN (Corporate Identification Number) of Shire Biotech India is U51909HR2017FTC070872. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Shire Biotech India is at 6th Floor Tower C Building No. 8 DLF Cyber City DLF Phase II, Gurgaon, Haryana, India – 122001.
Shire Biotech India can be reached through the website shire.com. Its registered office is in Gurgaon, Haryana, India.
The latest financial statements of Shire Biotech India on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 20 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Shire Biotech India is 06AAZCS2579N1Z8, registered in Haryana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAZCS2579N1Z6 (Delhi).
Shire Biotech India operated in the life sciences industry, in the biotechnology segment.
The peers of Shire Biotech India by revenue are VHB Life Sciences Limited, Trinity Pharmaceuticals & Food Private Limited, Unilex Lifesciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

